DUBAI, United Arab Emirates, March 24, 2022 (GLOBE NEWSWIRE) -- The growth of weight loss and obesity management market is attributed to the rising epidemic of obesity across the globe. According to the latest research by Future Market Insights (FMI), the global weight loss and obesity management market is anticipated to reach a valuation of over US$ 4.9 Bn, by the end of 2028. The weight loss and obesity management market is expected to expand at a steady CAGR of 5.2%, over the forecast period of 2022-2028.
| Weight Loss and Obesity Management Market Size (2022) | US$ 3.68 Bn | |
| Sales Forecast (2028) | US$ 4.99 Bn | |
| Global Market Growth Rate (2022 to 2028) | 5.2% CAGR | |
| Share of Top 5 Market Players | 50% | |
Developing Regions More Prone to Obesity & Other Comorbidities
Increasing number of cases of obesity and related comorbidities will lead to the growing adoption of drugs and devices for weight loss and obesity management, which will further fuel the growth of the global weight loss and obesity management market during the forecast period.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-411
The weight loss and obesity management market is majorly driven by the rising prevalence of obesity. The rising epidemic of obesity presents a major challenge to disease prevention across the globe. It is estimated that by 2030, 38% of the world’s adult population will be overweight and around 20% will be obese.
This obesity epidemic is more prevalent in the Middle East and the Asia Pacific regions where food import is quite high. Weight loss and obesity management are helpful in the treatment of highly critical obesity and comorbidities associated with it, such as diabetes, asthma, sleep apnea, and hypertension, etc.
Increasing health consciousness is also cited as an important factor boosting the revenue growth of the global weight loss and obesity management market. Sizeable consumer population in developed regional markets will particularly continue to generate high demand for weight loss and obesity management practices, according to the report.
Millennial and Generation-X consumers are gradually adopting advanced aesthetic services, including weight loss and obesity management, thereby creating adequate opportunities for manufacturers of weight loss and obesity management drugs and devices.
For critical insights on this market, request to ask an expert here @ https://www.futuremarketinsights.com/ask-question/rep-gb-411
Key Vendors Targeting Extension of Product Portfolio
Leading companies operating in weight loss and obesity management market are majorly focusing on strengthening their product portfolio. Product line extensions help companies to launch newer products with unique features for specific indications. This results in an increased market share of companies in the highly competitive weight loss and obesity management market.
In response to increasing demand from various healthcare professionals to effectively treat obesity with minimum long-term side effects, manufacturers are focusing on developing innovative and specific products.
Product innovation is expected to boost revenue and volume growth of the weight loss and obesity management market during the forecast period. For instance, an additional FDA patents approval for VIVUS, Inc.’s Qsymia, for the covering compositions of Qsymia and covering methods for effecting weight loss using Qsymia (phentermine and topiramate).
However, the high cost involved in research and development of obesity drugs is a great challenge for the growth of the weight loss and obesity management market. Additionally, long gestation time required for research and developmental activities as well as the need for a number of essential clinical trials to test drugs adds up to significant expenditure.
For More Information or Query or Customization Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-411
The limitations posed by high development cost of anti-obesity drugs might hinder the growth of the global weight loss and obesity management market. Moreover, the high cost of surgical procedures, such as gastric bypass surgery, adjustable gastric banding, gastric sleeve surgery and gastric balloon treatment, may also affect the growth of the global weight loss and obesity management market adversely.
The global weight loss and obesity management market is estimated based on product type, and distribution sales. Based on product type, the weight loss and obesity management market has been segmented into drugs and devices.
Drugs product type segment is further segmented into GLP-1 receptor agonists, lipase inhibitors, serotonin receptor agonist, a combination drug, and others. Devices product type segment is further segmented into liposuction devices, bariatric stapling devices, gastric band, gastric balloon systems, gastric emptying systems, and gastric electrical stimulation systems.
To Buy this Report Visit @ https://www.futuremarketinsights.com/checkout/411
Devices segment is expected to hold maximum market share in the global weight loss and obesity management market. Based on distribution sales, the weight loss and obesity management market has been segmented into institutional sales and retail sales. In terms of revenue, institutional sales dominated the global weight loss and obesity management market in 2017.
Explore wide-ranging Coverage of FMI's Healthcare Market Insights Landscape
DNA/RNA Extraction Market – Global DNA/RNA Extraction Market demand is anticipated to grow at a CAGR of 7.7% from 2022 to 2032.
Cystatin C Testing Market – Global Cystatin C Testing Market demand is anticipated to be valued at an impressive rate, expected to exhibit a significantly high CAGR throughout the 2022-2032 forecast period.
Creatine Kinase Reagent Market – Global creatine kinase reagent market demand is anticipated to grow at a CAGR of 6% from 2022 to 2032. The growth of the creatine kinase reagent market is attributed to its global utilization across the healthcare industry.
Immunochemistry Products Market – The immunochemistry products market is anticipated to record a CAGR of 7.25% during the forecast period, up from US$ 2.08 Bn in 2021 to reach a valuation of US$ 4.5 Bn by 2032.
Hemostats for Wound Closure Market – The Hemostats For Wound Closure Market expected to register a CAGR of 6.3% during the forecast period, up from US$ 2.4 Bn in 2021 to reach a valuation of US$ 3.5 Bn by 2026.
Smart Pill Technologies Market – The smart pill technologies market is projected to record a CAGR of 21% during the forecast period, up from US$ 627.1 Mn in 2020 to reach a valuation of US$ 6176 Mn by 2032.
Virology Market – The systemic lupus erythematosus (SLE) drugs market is projected to record a CAGR of 5% during the forecast period, up from US$ 183.3 Bn in 2020, to reach a valuation of US$ 329.18 Bn by 2032.
Systemic Lupus Erythematosus (SLE) Drugs Market – The virology market is projected to register a CAGR of 5% during the forecast period, up from US$ 2.07 Bn in 2021, to reach a valuation of US$ 3.53 Bn by 2032.
Stem Cell Therapy Market – The stem cell therapy market is expected to grow at a CAGR of 16.7% to USD 401 million by 2026, up from USD 187 million in 2021.
Breath Analyzers Market - The breath analyzers market is projected likely to register a CAGR of 17% during the forecast period, up from US$ 613 Mn in 2021 to reach a valuation of US$ 3.40 Bn by 2032.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centres in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/
Report : https://www.futuremarketinsights.com/reports/weight-loss-and-obesity-management-market
